Fentanyl Janssen

Fentanyl-Janssen may be available in the countries listed below.

Ingredient matches for Fentanyl-Janssen

Fentanyl

Fentanyl is reported as an ingredient of Fentanyl-Janssen in the following countries:

• Peru


• Tunisia


• Turkey

Fentanyl citrate (a derivative of Fentanyl) is reported as an ingredient of Fentanyl-Janssen in the following countries:

• Austria


• Bangladesh


• Costa Rica


• Czech Republic


• Dominican Republic


• El Salvador


• France


• Germany


• Greece


• Guatemala


• Honduras


• Hong Kong


• Malta


• Netherlands


• Nicaragua


• Panama


• Poland


• Romania


• Singapore


• Switzerland

International Drug Name Search

Aciclovir Winthrop

Aciclovir Winthrop may be available in the countries listed below.

Ingredient matches for Aciclovir Winthrop

Acyclovir

Aciclovir is reported as an ingredient of Aciclovir Winthrop in the following countries:

• France


• Portugal

International Drug Name Search

ranibizumab Intraocular

ra-ni-BIZ-oo-mab

Commonly used brand name(s)

In the U.S.

• Lucentis

Available Dosage Forms:

• Solution

Therapeutic Class: Ophthalmologic Agent

Pharmacologic Class: Monoclonal Antibody

Uses For ranibizumab

Ranibizumab is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina in the eye that causes blurring of vision or blindness.

ranibizumab is also used to treat macular edema (swelling of the back of the eye) after retinal vein occlusion (blockage of a blood vessel in the eye).

ranibizumab is available only with your doctor's prescription.

Before Using ranibizumab

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For ranibizumab, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to ranibizumab or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of ranibizumab in the pediatric population. Safety and efficacy have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of ranibizumab in the elderly.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	C	Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of ranibizumab. Make sure you tell your doctor if you have any other medical problems, especially:

• Eye infection or


• Infection around the eye—Should not be used in patients with these conditions.

• Glaucoma—Use with caution. May make this condition worse.

Proper Use of ranibizumab

An eye doctor will give you ranibizumab as a shot into the eye.

ranibizumab is usually given once a month (about every 28 days). In some patients, it may be given once every 3 months after the first 4 injections.

Precautions While Using ranibizumab

Your eye doctor will want to check your progress at regular visits, especially during the first few days after you receive ranibizumab.

Serious eye problems may occur with ranibizumab. Check with your eye doctor right away if your eye becomes red, sensitive to light, or painful, or if you have a change in vision several days after you receive ranibizumab. Also, tell your eye doctor if you feel increased pressure in the eye.

ranibizumab may increase your risk of blood clots. Check with your doctor right away if you are having pain in your chest, groin, or legs, especially the calves; difficulty with breathing; a severe, sudden headache; slurred speech; sudden, unexplained shortness of breath; sudden loss of coordination; sudden, severe weakness or numbness in your arm or leg; or vision changes.

ranibizumab Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur:

More common

• Blindness


• bloody eye


• blurred vision or loss of vision


• decreased vision or other changes in vision


• disturbed color perception


• dizziness


• double vision


• dry eye


• eye pain


• fainting


• feeling of having something in the eye


• halos around lights


• headache


• night blindness


• overbright appearance of lights


• pain or tenderness around the eyes and cheekbones


• red, sore eyes


• redness of the white part of the eyes or inside of the eyelids


• redness, swelling, or itching of the eyelid


• seeing flashes or sparks of light


• seeing floating spots before the eyes, or a veil or curtain appearing across part of vision


• sensitivity of the eye to light


• tearing of the eyes


• tunnel vision


• watering of the eyes

Less common

• Body aches or pain


• chest pain


• chills


• cough


• difficulty with breathing


• dry mouth


• fainting


• fast, slow, or irregular heartbeat


• general feeling of discomfort or illness


• head congestion


• hoarseness, loss of voice, or other voice changes


• loss of consciousness


• muscle aches and pains


• nasal congestion


• pain in the chest, groin, or legs, especially the calves


• painful blisters on the trunk of the body


• pale skin


• severe, sudden headache


• shivering


• shortness of breath


• slurred speech


• sneezing


• sore throat


• stuffy or runny nose


• sudden loss of coordination


• sudden, severe weakness or numbness in the arm or leg


• sudden, unexplained shortness of breath


• sweating


• tightness in the chest


• trouble sleeping


• troubled breathing


• unexplained weight loss


• unusual tiredness or weakness


• wheezing

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

• Back pain


• difficulty having a bowel movement (stool)


• difficulty with moving


• muscle stiffness


• sleeplessness


• swelling or redness in the joints


• unable to sleep

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: ranibizumab Intraocular side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More ranibizumab Intraocular resources

• Ranibizumab Intraocular Side Effects (in more detail)
• Ranibizumab Intraocular Use in Pregnancy & Breastfeeding
• Ranibizumab Intraocular Drug Interactions
• Ranibizumab Intraocular Support Group
• 1 Review for Ranibizumab Intraocular - Add your own review/rating

Compare ranibizumab Intraocular with other medications

• Diabetic Retinopathy
• Macular Degeneration
• Macular Edema

Reodyn

Reodyn may be available in the countries listed below.

Ingredient matches for Reodyn

Carbocisteine

Carbocisteine is reported as an ingredient of Reodyn in the following countries:

• Finland

International Drug Name Search

Anacort

Anacort may be available in the countries listed below.

Ingredient matches for Anacort

Hydrocortisone

Hydrocortisone 21-(hydrogen succinate) (a derivative of Hydrocortisone) is reported as an ingredient of Anacort in the following countries:

• Bangladesh

International Drug Name Search

Pellagra Medications

Definition of Pellagra: A disease caused by a deficient diet or failure of the body to absorb niacin (one of the B complex vitamins) or an amino acid (tryptophan). Common in certain parts of the world (in people consuming large quantities of corn), the disease is characterized by scaly skin sores, diarrhea, mucosal changes, and mental symptoms (especially a schizophrenia-likedementia). It may develop after gastrointestinal diseases or alcoholism.

Drugs associated with Pellagra

The following drugs and medications are in some way related to, or used in the treatment of Pellagra. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Pellagra

Medical Encyclopedia:

• Pellagra

Drug List:

B-3-50-Nicotinic-Acid

B3-500-Gr-Nicotinic-Acid

Niacin-Sr-Nicotinic-Acid

Niacor

Nicotinex

Slo-Niacin-Controlled-Release-Capsules

Clopidogrel-biomo

Clopidogrel-biomo may be available in the countries listed below.

Ingredient matches for Clopidogrel-biomo

Clopidogrel

Clopidogrel besilate (a derivative of Clopidogrel) is reported as an ingredient of Clopidogrel-biomo in the following countries:

• Germany

International Drug Name Search

Bezafibrato

Bezafibrato may be available in the countries listed below.

Ingredient matches for Bezafibrato

Bezafibrate

Bezafibrato (DCIT) is also known as Bezafibrate (Rec.INN)

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Mitomycin-Kyowa

Mitomycin-Kyowa may be available in the countries listed below.

Ingredient matches for Mitomycin-Kyowa

Mitomycin

Mitomycin is reported as an ingredient of Mitomycin-Kyowa in the following countries:

• China

International Drug Name Search

Apromed

Apromed may be available in the countries listed below.

Ingredient matches for Apromed

Naproxen

Naproxen sodium salt (a derivative of Naproxen) is reported as an ingredient of Apromed in the following countries:

• Turkey

International Drug Name Search

Lanacetine

Lanacetine may be available in the countries listed below.

Ingredient matches for Lanacetine

Chloramphenicol

Chloramphenicol is reported as an ingredient of Lanacetine in the following countries:

• Indonesia

Chloramphenicol palmitate (a derivative of Chloramphenicol) is reported as an ingredient of Lanacetine in the following countries:

• Indonesia

International Drug Name Search

Sertralin dura

Sertralin dura may be available in the countries listed below.

Ingredient matches for Sertralin dura

Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertralin dura in the following countries:

• Germany

International Drug Name Search

Adco-Ketotifen

Adco-Ketotifen may be available in the countries listed below.

Ingredient matches for Adco-Ketotifen

Ketotifen

Ketotifen fumarate (a derivative of Ketotifen) is reported as an ingredient of Adco-Ketotifen in the following countries:

• South Africa

International Drug Name Search

Cabergolin Teva

Cabergolin Teva may be available in the countries listed below.

Ingredient matches for Cabergolin Teva

Cabergoline

Cabergoline is reported as an ingredient of Cabergolin Teva in the following countries:

• Denmark


• Malta

International Drug Name Search

Doxar

Doxar may be available in the countries listed below.

Ingredient matches for Doxar

Doxazosin

Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Doxar in the following countries:

• Poland

International Drug Name Search

Epirubicina Microsules

Epirubicina Microsules may be available in the countries listed below.

Ingredient matches for Epirubicina Microsules

Epirubicin

Epirubicin hydrochloride (a derivative of Epirubicin) is reported as an ingredient of Epirubicina Microsules in the following countries:

• Argentina

International Drug Name Search

Diclofenac Solution

Pronunciation: dye-KLOE-fen-ak
Generic Name: Diclofenac
Brand Name: Pennsaid

Diclofenac Solution is a nonsteroidal anti-inflammatory drug (NSAID). It may cause an increased risk of serious and sometimes fatal heart and blood vessel problems (eg, a heart attack, stroke). The risk may be greater if you already have heart problems or if you use Diclofenac Solution for a long time. Do not use Diclofenac Solution right before or after bypass heart surgery.

Diclofenac Solution may cause an increased risk of serious and sometimes fatal stomach ulcers and bleeding. Elderly patients may be at greater risk. This may occur without warning signs.

Diclofenac Solution is used for:

Treating pain in the knee joints caused by osteoarthritis. It may also be used for other conditions as determined by your doctor.

Diclofenac Solution is an NSAID. Exactly how it works is not known. It may work by blocking certain substances in the body that are linked to inflammation. NSAIDs treat the symptoms of pain and inflammation. They do not treat the disease that causes those symptoms.

Do NOT use Diclofenac Solution if:

• you are allergic to any ingredient in Diclofenac Solution


• you have had a severe allergic reaction (eg, severe rash, hives, trouble breathing, growths in the nose, dizziness) to aspirin or another NSAID (eg, celecoxib, ibuprofen)


• you have recently had or will be having bypass heart surgery


• you have severe kidney problems


• you are in the last 3 months of pregnancy


• you are taking disulfiram or metronidazole

Contact your doctor or health care provider right away if any of these apply to you.

Before using Diclofenac Solution:

Some medical conditions may interact with Diclofenac Solution. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of kidney or liver problems, diabetes, or stomach or bowel problems (eg, bleeding, perforation, ulcers)


• if you have a history of swelling or fluid buildup, asthma, growths in the nose (nasal polyps), or mouth inflammation


• if you have high blood pressure, blood disorders (eg, porphyria), bone marrow problems, bleeding or clotting problems, heart problems (eg, heart failure), or blood vessel disease, or if you are at risk of any of these diseases


• if you have poor health, dehydration or low fluid volume, low blood sodium levels, you drink alcohol, or you have a history of alcohol abuse

Some MEDICINES MAY INTERACT with Diclofenac Solution. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Anticoagulants (eg, warfarin), aspirin, clopidogrel, corticosteroids (eg, prednisone), direct factor Xa inhibitors (eg, rivaroxaban), heparin, prasugrel, or selective serotonin reuptake inhibitors (SSRIs) (eg, fluoxetine) because the risk of bleeding, including stomach bleeding, may be increased


• Disulfiram, furazolidone, or metronidazole because a severe reaction that includes flushing, headache, fast or irregular heartbeat, trouble breathing, nausea, vomiting, and dizziness may occur


• Azole antifungals (eg, itraconazole, voriconazole), bisphosphonates (eg, risedronate), or probenecid because they may increase the risk of Diclofenac Solution's side effects


• Rifamycins (eg, rifampin) because they may decrease Diclofenac Solution's effectiveness


• Cyclosporine, lithium, methotrexate, oral NSAIDs (eg, ibuprofen), quinolones (eg, ciprofloxacin), or tenofovir because the risk of their side effects may be increased by Diclofenac Solution


• Angiotensin-converting enzyme (ACE) inhibitors (eg, enalapril) or diuretics (eg, furosemide, hydrochlorothiazide) because their effectiveness may be decreased by Diclofenac Solution


• Medicines that may harm the liver (eg, acetaminophen, ketoconazole, isoniazid, certain medicines for HIV infection, certain antibiotics or seizure medicines) because the risk of liver side effects may be increased. Ask your doctor if you are unsure if any of your medicines might harm the liver

This may not be a complete list of all interactions that may occur. Ask your health care provider if Diclofenac Solution may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Diclofenac Solution:

Use Diclofenac Solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Diclofenac Solution comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Diclofenac Solution refilled.


• Do not apply Diclofenac Solution to infected skin; open wounds; or red, swollen, or peeling skin.


• Wash your hands immediately before and after using Diclofenac Solution.


• Wash the affected area and dry completely before using Diclofenac Solution.


• To apply Diclofenac Solution, dispense 10 drops at a time onto the knee or into your hand. Spread Diclofenac Solution evenly around the front, back, and sides of the knee. Repeat until you have used the whole dose.


• Be sure that you cover your entire knee with your dose of Diclofenac Solution. Do not use more than the recommended amount.


• Do not apply sunscreens, cosmetics, insect repellants, other topical medicines, or any other substance to the treated area until it is completely dry.


• Do not put on clothes over the treated area until it is completely dry.


• Do not wrap, bandage, or apply heat to the treated area.


• Do not shower, bathe, or wash the treated area for at least 30 minutes after you use Diclofenac Solution.


• If you miss a dose of Diclofenac Solution, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Diclofenac Solution.

Important safety information:

• Diclofenac Solution may cause dizziness. This effect may be worse if you take it with alcohol or certain medicines. Use Diclofenac Solution with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Diclofenac Solution is for external use only. Do not get it in your eyes, nose, or mouth. If you get it in any of these areas, rinse right away with cool water.


• Serious stomach ulcers or bleeding can occur with the use of Diclofenac Solution. Taking it in high doses or for a long time, smoking, or drinking alcohol increases the risk of these side effects. Taking Diclofenac Solution with food will NOT reduce the risk of these effects. Contact your doctor or emergency room at once if you develop severe stomach or back pain; black, tarry stools; vomit that looks like blood or coffee grounds; or unusual weight gain or swelling.


• Do NOT use more than the recommended dose or use for longer than prescribed without checking with your doctor.


• Diclofenac Solution is an NSAID. Before you start any new medicine, check the label to see if it has an NSAID (eg, ibuprofen) in it too. If it does or if you are not sure, check with your doctor or pharmacist.


• Do not take aspirin while you are using Diclofenac Solution unless your doctor tells you to.


• Do not expose the treated area to the sun, sunlamps, or tanning booths.


• Diclofenac Solution may cause harm if it is swallowed. If you may have taken it by mouth, contact your poison control center or emergency room right away.


• Lab tests, including kidney and liver function, blood electrolyte levels, complete blood cell counts, and blood pressure, may be performed while you use Diclofenac Solution. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Use Diclofenac Solution with caution in the ELDERLY; they may be more sensitive to its effects, especially stomach bleeding and kidney problems.


• Diclofenac Solution should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: Diclofenac Solution may cause harm to the fetus. Do not use it during the last 3 months of pregnancy. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Diclofenac Solution while you are pregnant. It is not known if Diclofenac Solution is found in breast milk after topical use. Do not breast-feed while taking Diclofenac Solution.

Possible side effects of Diclofenac Solution:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation; diarrhea; dry skin or mild irritation at the application site; gas; nausea; stomach upset.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; trouble breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bloody or black, tarry stools; burning, numbness, or tingling of the skin; change in the amount of urine produced; chest pain; confusion; depression; fainting; fast or irregular heartbeat; fever, chills, or persistent sore throat; mental or mood changes; numbness of an arm or leg; one-sided weakness; red, swollen, blistered, or peeling skin; ringing in the ears; seizures; severe headache or dizziness; severe or persistent irritation at the application site; severe or persistent stomach pain or nausea; severe vomiting or diarrhea; shortness of breath; sudden or unexplained weight gain; swelling of the hands, legs, or feet; symptoms of liver problems (eg, dark urine, pale stools, persistent loss of appetite, yellowing of the skin or eyes, stomach pain, diarrhea); unusual bruising or bleeding; unusual joint or muscle pain; unusual tiredness or weakness; vision or speech changes; vomit that looks like coffee grounds.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include decreased urination; loss of consciousness; seizures; severe dizziness or drowsiness; severe nausea, vomiting, or stomach pain; slow or troubled breathing; tremor; unusual bleeding or bruising; vomit that looks like coffee grounds.

Proper storage of Diclofenac Solution:

Store Diclofenac Solution at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Diclofenac Solution out of the reach of children and away from pets.

General information:

• If you have any questions about Diclofenac Solution, please talk with your doctor, pharmacist, or other health care provider.


• Diclofenac Solution is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Diclofenac Solution. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Diclofenac resources

• Diclofenac Use in Pregnancy & Breastfeeding
• Diclofenac Drug Interactions
• Diclofenac Support Group
• 83 Reviews for Diclofenac - Add your own review/rating

Compare Diclofenac with other medications

• Actinic Keratosis
• Osteoarthritis
• Pain

Agricillin

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Agricillin

Benzylpenicillin

Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Agricillin in the following countries:

• United States

International Drug Name Search

Anlet

Anlet may be available in the countries listed below.

Ingredient matches for Anlet

Clopidogrel

Clopidogrel hydrogen sulfate (a derivative of Clopidogrel) is reported as an ingredient of Anlet in the following countries:

• Bangladesh

International Drug Name Search

Pregmagon

Pregmagon may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Pregmagon

Gonadotrophin, Serum

Gonadotrophin, Serum is reported as an ingredient of Pregmagon in the following countries:

• Germany

International Drug Name Search

Acne Crème Plus Widmer

Acne Crème Plus Widmer may be available in the countries listed below.

Ingredient matches for Acne Crème Plus Widmer

Benzoyl Peroxide

Benzoyl Peroxide is reported as an ingredient of Acne Crème Plus Widmer in the following countries:

• Switzerland

Miconazole

Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Acne Crème Plus Widmer in the following countries:

• Switzerland

International Drug Name Search

DDAVP nasal

Generic Name: desmopressin (nasal) (DEZ mo press in)

Brand Names: DDAVP Nasal, DDAVP Rhinal Tube, Stimate

What is DDAVP (desmopressin (nasal))?

Desmopressin is a man-made form of a hormone that occurs naturally in the pituitary gland. This hormone is important for many functions including blood flow, blood pressure, kidney function, and regulating how the body uses water.

Desmopressin nasal is used to treat central cranial diabetes insipidus, and increased thirst and urination caused by head surgery or head trauma.

Desmopressin nasal is also used to treat hemophilia A or von Willebrand's disease Type I.

Desmopressin nasal may also be used for other purposes not listed in this medication guide.

What is the most important information I should know about DDAVP (desmopressin (nasal))?

It is very important to reduce your intake of water and other fluids while you are using desmopressin. Drinking too much water can cause your body to lose sodium, which may lead to a serious, life-threatening electrolyte imbalance.

Fluid restriction is especially important in children and older adults using desmopressin nasal. Follow your doctor's instructions about the type and amount of liquids you should drink.

You should not use this medication if you have severe kidney disease or if you have ever had hyponatremia (low sodium levels in your body).

Before using desmopressin nasal, tell your doctor if you have heart disease, coronary artery disease, congestive heart failure, kidney disease, cystic fibrosis, high or low blood pressure, an electrolyte imbalance, or a psychological disorder that causes extreme or unusual thirst.

Desmopressin nasal may be less effective if you have any swelling or scarring inside your nose, or any nasal or sinus problems (such as deviated septum).

This medication comes with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.

To be sure desmopressin nasal is helping your condition, your blood will need to be tested often. This will help your doctor determine how long to treat you with this medication. Do not miss any scheduled appointments.

What should I discuss with my healthcare provider before using DDAVP (desmopressin (nasal))?

You should not use this medication if you are allergic to desmopressin, or if you have:

• 
  

  severe kidney disease; or

  
  


• 
  

  if you have ever had hyponatremia (low sodium levels in your body).

  
  

Before using desmopressin nasal, tell your doctor if you are allergic to any medications, or if you have:

• 
  

  heart disease, coronary artery disease;

  
  


• 
  

  congestive heart failure;

  
  


• 
  

  kidney disease;

  
  


• 
  

  cystic fibrosis;

  
  


• 
  

  high or low blood pressure;

  
  


• 
  

  an electrolyte imbalance; or

  
  


• 
  

  a psychologic disorder that causes extreme or unusual thirst.

  
  

If you have any of these conditions, you may need a dose adjustment or special tests to safely use desmopressin.

Desmopressin nasal may be less effective if you have any swelling or scarring inside your nose, or any nasal or sinus problems (such as deviated septum).

FDA pregnancy category B. This medication is not expected to harm an unborn baby. Do not use desmopressin nasal without telling your doctor if you are pregnant. It is not known whether desmopressin nasal passes into breast milk, or if it could harm a nursing baby. Do not use desmopressin nasal without telling your doctor if you are breast-feeding a baby.

How should I use DDAVP (desmopressin (nasal))?

Use this medication exactly as prescribed by your doctor. Do not use it in larger amounts or for longer than recommended. Follow the directions on your prescription label.

This medication comes with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.

It is very important to reduce your intake of water and other fluids while you are using desmopressin. Drinking too much water can cause your body to lose sodium, which may lead to a serious, life-threatening electrolyte imbalance.

Fluid restriction is especially important in children and older adults using desmopressin nasal. Follow your doctor's instructions about the type and amount of liquids you should drink.

Before using desmopressin nasal spray for the first time, prime the spray pump by pressing down on the pump 4 times.

To be sure this medication is helping your condition, your blood will need to be tested often. This will help your doctor determine how long to treat you with desmopressin nasal. Do not miss any scheduled appointments.

Keep track of how many sprays have been used from each bottle of desmopressin nasal spray. Stimate nasal spray contains enough desmopressin for the priming spray plus 25 full sprays. DDAVP nasal spray contains enough desmopressin for the priming spray plus 50 sprays. Your patient instructions may include a check-off chart to help you keep an accurate record or sprays you use. If you are treating hemophilia or von Willebrand's disease, call your doctor if your bleeding is not controlled during treatment with desmopressin nasal.

The desmopressin nasal spray bottle should be thrown away after the specified number of sprays have been used, even if there is medicine leftover in the bottle. Do not try to pour solution from one bottle to another.

Store DDAVP nasal spray at room temperature away from moisture and heat. Keep the bottle in an upright position when not in use. Store Stimate nasal spray or DDAVP Rhinal Tube in the refrigerator. Do not freeze. If refrigeration is not available, you may keep the closed bottles at room temperature for up to 3 weeks.

What happens if I miss a dose?

Use the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to use the medicine and skip the missed dose. Do not use extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention if you think you have used too much of this medicine.

Overdose symptoms may include headache, confusion, drowsiness, rapid weight gain, or urination problems.

What should I avoid while using DDAVP (desmopressin (nasal))?

Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are using desmopressin.

DDAVP (desmopressin (nasal)) side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using desmopressin nasal and call your doctor at once if you have any of these serious side effects:

• 
  

  nausea, vomiting, weakness, loss of appetite, headache, feeling restless or irritable, confusion, hallucinations, muscle pain or weakness, and/or seizure;

  
  


• 
  

  feeling like you might pass out;

  
  


• 
  

  swelling;

  
  


• 
  

  chest pain, fast or pounding heart rate;

  
  


• 
  

  vaginal pain;

  
  


• 
  

  nosebleed; or

  
  


• 
  

  dangerously high blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, confusion, chest pain, shortness of breath, uneven heartbeats, seizure).

  
  

Less serious side effects may include:

• 
  

  runny or stuffy nose;

  
  


• 
  

  sore throat, cough, or other cold symptoms;

  
  


• 
  

  eye redness or watering;

  
  


• 
  

  eye itching or increased sensitivity to light;

  
  


• 
  

  headache, weakness;

  
  


• 
  

  feeling dizzy or agitated;

  
  


• 
  

  nausea, vomiting, stomach pain;

  
  


• 
  

  hot or cold feeling; or

  
  


• 
  

  warmth, redness, or tingly feeling in your face.

  
  

This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect DDAVP (desmopressin (nasal))?

Many drugs can interact with desmopressin nasal. Below is just a partial list. Tell your doctor if you are using:

• 
  

  carbamazepine (Carbatrol, Tegretol);

  
  


• 
  

  chlorpromazine (Thorazine);

  
  


• 
  

  lamotrigine (Lamictal);

  
  


• 
  

  oxybutynin (Ditropan, Urotrol, Oxytrol);

  
  


• 
  

  vasopressin (Pitressin);

  
  


• 
  

  a narcotic pain medicine such as fentanyl (Actiq, Duragesic), hydrocodone (Lortab, Vicodin), oxycodone (Oxycontin), and others;

  
  


• 
  

  an "SSRI" antidepressant such as citalopram (Celexa), escitalopram (Lexapro), fluoxetine (Prozac, Sarafem), fluvoxamine (Luvox), paroxetine (Paxil), or sertraline (Zoloft);

  
  


• 
  

  a tricyclic antidepressant such as amitriptyline (Elavil, Etrafon), clomipramine (Anafranil), desipramine (Norpramin), doxepin (Sinequan), imipramine (Janimine, Tofranil), and others;

  
  


• 
  

  medicine to treat erectile dysfunction, such as sildenafil (Viagra), tadalafil (Cialis), or vardenafil (Levitra);

  
  


• 
  

  drugs to treat high blood pressure or a prostate disorder, such as alfuzosin (Uroxatral), doxazosin (Cardura), prazosin (Minipress), terazosin (Hytrin), tamsulosin (Flomax);

  
  


• 
  

  a beta-blocker such as atenolol (Tenormin), bisoprolol (Zebeta, Ziac), labetalol (Normodyne, Trandate), metoprolol (Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal, InnoPran), sotalol (Betapace), or timolol (Blocadren); or

  
  


• 
  

  an NSAID (non-steroidal anti-inflammatory drug) such as ibuprofen (Motrin, Advil), naproxen (Aleve, Naprosyn), diclofenac (Cataflam, Voltaren), etodolac (Lodine), indomethacin (Indocin), and others.

  
  

This list is not complete and there may be other drugs that can interact with desmopressin nasal. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.

More DDAVP resources

• DDAVP Side Effects (in more detail)
• DDAVP Use in Pregnancy & Breastfeeding
• Drug Images
• DDAVP Drug Interactions
• DDAVP Support Group
• 6 Reviews for DDAVP - Add your own review/rating

• Desmopressin Prescribing Information (FDA)


• DDAVP Prescribing Information (FDA)


• DDAVP MedFacts Consumer Leaflet (Wolters Kluwer)


• DDAVP Advanced Consumer (Micromedex) - Includes Dosage Information


• Desmopressin Acetate Monograph (AHFS DI)


• Minirin Spray MedFacts Consumer Leaflet (Wolters Kluwer)


• Stimate Prescribing Information (FDA)


• Stimate Spray MedFacts Consumer Leaflet (Wolters Kluwer)

Compare DDAVP with other medications

• Diabetes Insipidus
• Hemophilia A
• Primary Nocturnal Enuresis
• von Willebrand's Disease

Where can I get more information?

• Your pharmacist can provide more information about desmopressin nasal.

See also: DDAVP side effects (in more detail)

Apo-Lisinopril / HCTZ

Apo-Lisinopril/HCTZ may be available in the countries listed below.

Ingredient matches for Apo-Lisinopril/HCTZ

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Apo-Lisinopril/HCTZ in the following countries:

• Canada

Lisinopril

Lisinopril is reported as an ingredient of Apo-Lisinopril/HCTZ in the following countries:

• Canada

International Drug Name Search

Breacol

Breacol may be available in the countries listed below.

Ingredient matches for Breacol

Guaifenesin

Guaifenesin is reported as an ingredient of Breacol in the following countries:

• Singapore

International Drug Name Search

Aciclovir Jet

Aciclovir Jet may be available in the countries listed below.

Ingredient matches for Aciclovir Jet

Acyclovir

Aciclovir is reported as an ingredient of Aciclovir Jet in the following countries:

• Italy

International Drug Name Search

Ceractiv

Ceractiv may be available in the countries listed below.

Ingredient matches for Ceractiv

Pemoline

Pemoline is reported as an ingredient of Ceractiv in the following countries:

• Chile

International Drug Name Search

Lysomucil Junior

Lysomucil Junior may be available in the countries listed below.

Ingredient matches for Lysomucil Junior

Acetylcysteine

Acetylcysteine is reported as an ingredient of Lysomucil Junior in the following countries:

• Belgium

International Drug Name Search

Atenosafe

Atenosafe may be available in the countries listed below.

Ingredient matches for Atenosafe

Atenolol

Atenolol is reported as an ingredient of Atenosafe in the following countries:

• Japan

International Drug Name Search

Valnemulin

In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0101312-92-9

Chemical Formula

C31-H52-N2-O5-S

Molecular Weight

564

Therapeutic Category

Antibacterial

Chemical Name

[[2-[(R)-2-Amino-3-methylbutyramido]-1,1-dimethylethyl]thio]acetic acid, 8-ester with (3aS,4R,5S,6S,8R,9R,9aR,10R)-octahydro-5,8-dihydroxy-4,6,9,10-tetramethyl-6-vinyl-3a,9-propano-3aH-cyclopentacycloocten-1(4H)-one

Foreign Names

• Valnemulinum (Latin)
• Valnemulin (German)
• Valnemuline (French)
• Valnemulina (Spanish)

Generic Names

• Valnemulin (OS: BAN)
• Valnemulin Hydrochloride (OS: BAN)
• Valnemulin Hydrochloride (PH: BP vet. 2007)
• Valnemulin Hydrochloride for Veterinary Use (PH: Ph. Eur. 6)
• Valnemulini hydrochloridum ad usum veterinarium (PH: Ph. Eur. 6)

Brand Names

• Econor (veterinary use)
  Bioptive, Germany; Novartis Animal Health, Austria; Novartis Animal Health, United Kingdom; Novartis Animal Health, Italy; Novartis Animal Health, Sweden; Novartis Tiergesundheit, Switzerland; Novartis vet., Finland; V.M.D, Belgium

International Drug Name Search

Glossary

BAN	British Approved Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Cloxacillin-Benzathin

Cloxacillin-Benzathin may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Cloxacillin-Benzathin

Cloxacillin

Cloxacillin benzathine (a derivative of Cloxacillin) is reported as an ingredient of Cloxacillin-Benzathin in the following countries:

• Germany

International Drug Name Search

Calcisan

Calcisan may be available in the countries listed below.

Ingredient matches for Calcisan

Calcium

Calcium mixture of several salts (a derivative of Calcium) is reported as an ingredient of Calcisan in the following countries:

• Austria

International Drug Name Search

Dostinex

In the US, Dostinex (cabergoline systemic) is a member of the following drug classes: dopaminergic antiparkinsonism agents, prolactin inhibitors and is used to treat Hyperprolactinemia.

US matches:

• Dostinex

UK matches:

• Dostinex Tablets (SPC)

Ingredient matches for Dostinex

Cabergoline

Cabergoline is reported as an ingredient of Dostinex in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Belgium


• Brazil


• Canada


• Chile


• Colombia


• Costa Rica


• Czech Republic


• Ecuador


• El Salvador


• Finland


• France


• Georgia


• Germany


• Greece


• Guatemala


• Honduras


• Hong Kong


• Iceland


• Ireland


• Israel


• Italy


• Latvia


• Lithuania


• Luxembourg


• Malaysia


• Malta


• Mexico


• Netherlands


• New Zealand


• Nicaragua


• Norway


• Oman


• Panama


• Peru


• Poland


• Portugal


• Romania


• Russian Federation


• Singapore


• South Africa


• Spain


• Sweden


• Switzerland


• Taiwan


• Tunisia


• Turkey


• United Kingdom


• United States


• Venezuela

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Périndopril

Périndopril may be available in the countries listed below.

Ingredient matches for Périndopril

Perindopril

Périndopril (DCF) is known as Perindopril in the US.

International Drug Name Search

Glossary

DCF	Dénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Zyntabac

Zyntabac may be available in the countries listed below.

Ingredient matches for Zyntabac

Bupropion

Bupropion hydrochloride (a derivative of Bupropion) is reported as an ingredient of Zyntabac in the following countries:

• Spain

International Drug Name Search

Gen-Verapamil

Gen-Verapamil may be available in the countries listed below.

Ingredient matches for Gen-Verapamil

Verapamil

Verapamil hydrochloride (a derivative of Verapamil) is reported as an ingredient of Gen-Verapamil in the following countries:

• Canada

International Drug Name Search

Bezafibrat Genericon

Bezafibrat Genericon may be available in the countries listed below.

Ingredient matches for Bezafibrat Genericon

Bezafibrate

Bezafibrate is reported as an ingredient of Bezafibrat Genericon in the following countries:

• Austria

International Drug Name Search

Drovid

Drovid may be available in the countries listed below.

Ingredient matches for Drovid

Ofloxacin

Ofloxacin is reported as an ingredient of Drovid in the following countries:

• Turkey

International Drug Name Search

Avizol

Avizol may be available in the countries listed below.

Ingredient matches for Avizol

Omeprazole

Omeprazole is reported as an ingredient of Avizol in the following countries:

• India

International Drug Name Search

Hapacol Flu

Hapacol Flu may be available in the countries listed below.

Ingredient matches for Hapacol Flu

Chlorphenamine

Chlorphenamine maleate (a derivative of Chlorphenamine) is reported as an ingredient of Hapacol Flu in the following countries:

• Vietnam

Paracetamol

Paracetamol is reported as an ingredient of Hapacol Flu in the following countries:

• Vietnam

International Drug Name Search

Omeprazol Gastrol

Omeprazol Gastrol may be available in the countries listed below.

Ingredient matches for Omeprazol Gastrol

Omeprazole

Omeprazole is reported as an ingredient of Omeprazol Gastrol in the following countries:

• Portugal

International Drug Name Search

Glucosamine ratiopharm

Glucosamine ratiopharm may be available in the countries listed below.

Ingredient matches for Glucosamine ratiopharm

Glucosamine

Glucosamine sulfate sodium chloride (a derivative of Glucosamine) is reported as an ingredient of Glucosamine ratiopharm in the following countries:

• Sweden

International Drug Name Search

Queenpress

Queenpress may be available in the countries listed below.

Ingredient matches for Queenpress

Prazosin

Prazosin hydrochloride (a derivative of Prazosin) is reported as an ingredient of Queenpress in the following countries:

• Japan

International Drug Name Search

Fentanyl Citrato Hospira

Fentanyl Citrato Hospira may be available in the countries listed below.

Ingredient matches for Fentanyl Citrato Hospira

Fentanyl

Fentanyl citrate (a derivative of Fentanyl) is reported as an ingredient of Fentanyl Citrato Hospira in the following countries:

• Peru

International Drug Name Search

Nu-Triazide

Nu-Triazide may be available in the countries listed below.

Ingredient matches for Nu-Triazide

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Nu-Triazide in the following countries:

• Canada

Triamterene

Triamterene is reported as an ingredient of Nu-Triazide in the following countries:

• Canada

International Drug Name Search

Cysten

Cysten may be available in the countries listed below.

Ingredient matches for Cysten

Cinnarizine

Cinnarizine is reported as an ingredient of Cysten in the following countries:

• Japan

International Drug Name Search

Cerazette

Cerazette may be available in the countries listed below.

UK matches:

• Cerazette 75 microgram film-coated tablet (SPC)

Ingredient matches for Cerazette

Desogestrel

Desogestrel is reported as an ingredient of Cerazette in the following countries:

• Argentina


• Austria


• Bahrain


• Belgium


• Brazil


• Chile


• Colombia


• Costa Rica


• Czech Republic


• Denmark


• Dominican Republic


• Estonia


• Finland


• France


• Germany


• Greece


• Guatemala


• Honduras


• Hungary


• Iceland


• Indonesia


• Ireland


• Israel


• Italy


• Latvia


• Lithuania


• Luxembourg


• Mexico


• Netherlands


• New Zealand


• Nicaragua


• Norway


• Oman


• Panama


• Peru


• Philippines


• Poland


• Portugal


• Slovakia


• Slovenia


• Sweden


• Switzerland


• United Kingdom


• Venezuela

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Crono-Gest Spugne

Crono-Gest Spugne may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Crono-Gest Spugne

Flugestone

Flugestone 17α-acetate (a derivative of Flugestone) is reported as an ingredient of Crono-Gest Spugne in the following countries:

• Italy

International Drug Name Search

Aciclovir T.S.

Aciclovir T.S. may be available in the countries listed below.

Ingredient matches for Aciclovir T.S.

Acyclovir

Aciclovir is reported as an ingredient of Aciclovir T.S. in the following countries:

• Italy

International Drug Name Search

ASA

ASA may be available in the countries listed below.

Ingredient matches for ASA

Aspirin

Acetylsalicylic Acid is reported as an ingredient of ASA in the following countries:

• Hungary


• India

International Drug Name Search

Medejion

Medejion may be available in the countries listed below.

Ingredient matches for Medejion

Epinastine

Epinastine hydrochloride (a derivative of Epinastine) is reported as an ingredient of Medejion in the following countries:

• Japan

International Drug Name Search

Aciclovir Kern Pharma

Aciclovir Kern Pharma may be available in the countries listed below.

Ingredient matches for Aciclovir Kern Pharma

Acyclovir

Aciclovir is reported as an ingredient of Aciclovir Kern Pharma in the following countries:

• Spain

International Drug Name Search

Dermodrin

Dermodrin may be available in the countries listed below.

Ingredient matches for Dermodrin

Diphenhydramine

Diphenhydramine hydrochloride (a derivative of Diphenhydramine) is reported as an ingredient of Dermodrin in the following countries:

• Austria


• Bulgaria

International Drug Name Search

Diosmine CristerS

Diosmine CristerS may be available in the countries listed below.

Ingredient matches for Diosmine CristerS

Diosmin

Diosmin is reported as an ingredient of Diosmine CristerS in the following countries:

• France

International Drug Name Search

Préviscan

Préviscan may be available in the countries listed below.

Ingredient matches for Préviscan

Fluindione

Fluindione is reported as an ingredient of Préviscan in the following countries:

• France


• Luxembourg

International Drug Name Search

Dulcolactol

Dulcolactol may be available in the countries listed below.

Ingredient matches for Dulcolactol

Lactulose

Lactulose is reported as an ingredient of Dulcolactol in the following countries:

• Indonesia

International Drug Name Search

Argatroban

In the US, Argatroban (argatroban systemic) is a member of the drug class thrombin inhibitors and is used to treat Thrombotic/Thromboembolic Disorder.

US matches:

• Argatroban


• Argatroban Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B01AE03

CAS registry number (Chemical Abstracts Service)

0074863-84-6

Chemical Formula

C23-H36-N6-O5-S

Molecular Weight

508

Therapeutic Category

Anticoagulant agent: Direct thrombin inhibitor

Chemical Name

(2R,4R)-4-Methyl-1-[(S)-N²-[[(RS)-1,2,3,4-tetrahydro-3-methyl-8-quinolyl]sulfonyl]arginyl]pipecolic acid

Foreign Names

• Argatrobanum (Latin)
• Argatroban (German)
• Argatroban (French)
• Argatroban (Spanish)

Generic Names

• Argatroban (OS: JAN, USAN, BAN)
• Argipidine (IS)
• MQPA (IS)
• DK 7419 (IS)
• GN 1600 (IS)
• MCI 9038 (IS: Mitsubishi)
• MD 805 (IS: Mitsubishi)
• OM 805 (IS)

Brand Names

• Arganova
  Mitsubishi, Netherlands



• Argaron
  Nichi-Iko PharmaceuticalJMA, Japan



• Argatra
  Mitsubishi, Austria; Mitsubishi, Germany



• Argatroban
  Encysive, United States



• Gartban
  Shiono Kemikaru, Japan



• Novastan
  Biovitrum, Sweden; Italchimici, Italy; Mitsubishi, China; Mitsubishi, Norway; Mitsubishi Pharma Europe Ltd., Denmark; Tanabe Mitsubishi, Japan



• Novastan HI
  Tanabe Mitsubishi, Japan



• Argatroban
  GlaxoSmithKline, United States



• Slonnon Hi
  Daiichi Sankyo, Japan



• Slovastan
  Sawai Seiyaku, Japan

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Forcan

Forcan may be available in the countries listed below.

Ingredient matches for Forcan

Fluconazole

Fluconazole is reported as an ingredient of Forcan in the following countries:

• Bahrain


• Czech Republic


• India


• Latvia


• Oman


• Sri Lanka


• Vietnam

International Drug Name Search

Progynon

Progynon may be available in the countries listed below.

Ingredient matches for Progynon

Estradiol

Estradiol 17ß-valerate (a derivative of Estradiol) is reported as an ingredient of Progynon in the following countries:

• Denmark


• Iceland


• Japan


• Sweden

International Drug Name Search

Cosaar Plus Paranova

Cosaar Plus Paranova may be available in the countries listed below.

Ingredient matches for Cosaar Plus Paranova

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Cosaar Plus Paranova in the following countries:

• Denmark

Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Cosaar Plus Paranova in the following countries:

• Denmark

International Drug Name Search

Flucytsine

Flucytsine may be available in the countries listed below.

Ingredient matches for Flucytsine

Flucytosine

Flucytosine is reported as an ingredient of Flucytsine in the following countries:

• New Zealand

International Drug Name Search

Acralion

Acralion may be available in the countries listed below.

Ingredient matches for Acralion

Sulbutiamine

Sulbutiamine is reported as an ingredient of Acralion in the following countries:

• Aruba


• Bahamas


• Barbados


• Bermuda


• Cayman Islands


• Grenada


• Guyana


• Jamaica


• Netherlands Antilles


• Saint Lucia


• Saint Vincent & The Grenadines


• Trinidad & Tobago

International Drug Name Search

DuoPlant

In the US, DuoPlant (salicylic acid topical) is a member of the following drug classes: topical acne agents, topical keratolytics and is used to treat Acne and Warts.

US matches:

• Duoplant Gel


• Duoplant Topical

Ingredient matches for DuoPlant

Salicylic Acid

Salicylic Acid is reported as an ingredient of DuoPlant in the following countries:

• Chile


• Costa Rica


• Dominican Republic


• El Salvador


• Guatemala


• Honduras


• Mexico


• Nicaragua


• Panama


• Peru


• United States


• Venezuela

International Drug Name Search

Predinga

Predinga may be available in the countries listed below.

Ingredient matches for Predinga

Prednisolone

Prednisolone is reported as an ingredient of Predinga in the following countries:

• Sri Lanka

International Drug Name Search

Ergix toux sèche

Ergix toux sèche may be available in the countries listed below.

Ingredient matches for Ergix toux sèche

Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Ergix toux sèche in the following countries:

• France

International Drug Name Search

Kancin

Kancin may be available in the countries listed below.

Ingredient matches for Kancin

Kanamycin

Kanamycin is reported as an ingredient of Kancin in the following countries:

• India

Kanamycin sulfate (a derivative of Kanamycin) is reported as an ingredient of Kancin in the following countries:

• India


• Singapore

International Drug Name Search

Ivomec Comp

Ivomec Comp may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ivomec Comp

Ivermectin

Ivermectin is reported as an ingredient of Ivomec Comp in the following countries:

• Finland


• Norway

Praziquantel

Praziquantel is reported as an ingredient of Ivomec Comp in the following countries:

• Finland


• Norway

International Drug Name Search

Loestrin Fe 1.5 / 30

See also: Generic Loestrin 21 1.5/30, Generic Loestrin 21 1/20, Generic Loestrin 24 Fe, Generic Loestrin Fe 1/20

Loestrin Fe 1.5/30 is a brand name of ethinyl estradiol/norethindrone, approved by the FDA in the following formulation(s):

LOESTRIN FE 1.5/30 (ethinyl estradiol; norethindrone acetate - tablet; oral-28)

• 
  Manufacturer: WARNER CHILCOTT
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 0.03MG;1.5MG ^[RLD][AB]

Has a generic version of Loestrin Fe 1.5/30 been approved?

Yes. The following products are equivalent to Loestrin Fe 1.5/30:

GILDESS FE 1.5/30 (ethinyl estradiol; norethindrone acetate tablet; oral-28)

• 
  Manufacturer: VINTAGE
  
  Approval date: April 28, 2005
  
  Strength(s): 0.03MG;1.5MG ^[AB]

JUNEL FE 1.5/30 (ethinyl estradiol; norethindrone acetate tablet; oral-28)

• 
  Manufacturer: BARR
  
  Approval date: September 18, 2003
  
  Strength(s): 0.03MG;1.5MG ^[AB]

MICROGESTIN FE 1.5/30 (ethinyl estradiol; norethindrone acetate tablet; oral-28)

• 
  Manufacturer: WATSON LABS
  
  Approval date: February 5, 2001
  
  Strength(s): 0.03MG;1.5MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Loestrin Fe 1.5/30. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Loestrin Fe 1.5/30.

See also...

• Loestrin Fe 1.5/30 Consumer Information (Cerner Multum)
• Ortho-Novum Consumer Information (Drugs.com)
• Norethindrone/Ethinyl Estradiol Consumer Information (Wolters Kluwer)
• Norethindrone/Ethinyl Estradiol (HRT) Consumer Information (Wolters Kluwer)
• Norethindrone/Ethinyl Estradiol Chewable Tablets Consumer Information (Wolters Kluwer)
• Norethindrone/Ethinyl Estradiol Tablets Consumer Information (Wolters Kluwer)
• Ethinyl estradiol and norethindrone Consumer Information (Cerner Multum)
• Ethinyl estradiol and norethindrone HRT Consumer Information (Cerner Multum)
• Norethindrone, ethinyl estradiol, and ferrous fumarate Advanced Consumer Information (Micromedex)

Bupicaina

Bupicaina may be available in the countries listed below.

Ingredient matches for Bupicaina

Bupivacaine

Bupivacaine hydrochloride (a derivative of Bupivacaine) is reported as an ingredient of Bupicaina in the following countries:

• Argentina

International Drug Name Search

Aciclovir Merck

Aciclovir Merck may be available in the countries listed below.

Ingredient matches for Aciclovir Merck

Acyclovir

Aciclovir is reported as an ingredient of Aciclovir Merck in the following countries:

• Spain


• Tunisia

International Drug Name Search

Cexyl

Cexyl may be available in the countries listed below.

Ingredient matches for Cexyl

Cefadroxil

Cefadroxil monohydrate (a derivative of Cefadroxil) is reported as an ingredient of Cexyl in the following countries:

• Romania

International Drug Name Search

Zylohist

Zylohist may be available in the countries listed below.

Ingredient matches for Zylohist

Loratadine

Loratadine is reported as an ingredient of Zylohist in the following countries:

• Philippines

International Drug Name Search

Estradiol 2care4

Estradiol 2care4 may be available in the countries listed below.

Ingredient matches for Estradiol 2care4

Estradiol

Estradiol is reported as an ingredient of Estradiol 2care4 in the following countries:

• Denmark

International Drug Name Search

Aremis

Aremis may be available in the countries listed below.

Ingredient matches for Aremis

Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Aremis in the following countries:

• Spain

International Drug Name Search

Vitamina E 500 Arko

Vitamina E 500 Arko may be available in the countries listed below.

Ingredient matches for Vitamina E 500 Arko

Tocopherol, α-

Tocopherol, α- acetate (a derivative of Tocopherol, α-) is reported as an ingredient of Vitamina E 500 Arko in the following countries:

• Spain

International Drug Name Search

Aciclovir Dakota Pharm

Aciclovir Dakota Pharm may be available in the countries listed below.

Ingredient matches for Aciclovir Dakota Pharm

Acyclovir

Aciclovir is reported as an ingredient of Aciclovir Dakota Pharm in the following countries:

• France

International Drug Name Search